Image of Breast cancer trial with erythropoietin terminated unexpectedly

LITERATURE

Breast cancer trial with erythropoietin terminated unexpectedly


Many clinical studies have shown an association between tumour oxygenation, higher haemoglobin concentrations, and improved survival in patients with cancer.1–6 And, in a recent prospective, randomised study, a subpopulation of anaemic patients with metastatic breast cancer were shown to survive longer if given erythropoietin to correct their haemoglobin concentration during chemotherapy than if treated with placebo


Availability

NESP-005Titan CenterAvailable

Detail Information

Series Title
-
Call Number
-
Publisher : .,
Collation
-
Language
English
ISBN/ISSN
-
Classification
NONE
Content Type
-
Media Type
-
Carrier Type
-
Edition
-
Subject(s)
Specific Detail Info
THE LANCET Oncology Vol 4 August 2003
Statement of Responsibility

Other version/related

No other version available


File Attachment



Information


RECORD DETAIL


Back To Previous